Embedding Patient Centricity- Understanding the role of real-world evidence in global market access strategies
 This presentation is no longer available.


When planning your market access strategy, are you including the patient voice?

Can real-world evidence-based research help provide a patient-centric perspective when communicating the value of new treatments to payers?

Join Dr Louise Parmenter and Dr Stella Blackburn from Quintiles as they discuss the importance of embedding patient centricity into the development of real-world evidence in global market access strategies.


Key learning objectives

uncover the best practice approaches for including of the patient voice in market access strategies to provide real-world evidence

understand the viewpoint of an ex-regulator on how to provide real-world evidence with a patient-centric end point in mind


Who should attend

Market Access, Medical and Regulatory Affairs, Real-World Late Phase Research, Health Economics Outcomes Research, Brand Managers 



Dr Louise Parmenter, Global Head of Operations, Epidemiology and Outcomes Research, Real-World and Late Phase at Quintiles

Dr Stella Blackburn, Vice President, Global Head of Risk Management, Real-World and Late Phase Research at Quintiles


Presented by
PharmExec Logo

Sponsored by
Quintiles Logo

For questions, contact Sara Barschdorf at sbarschdorf@advanstar.com

  Test Your System
  Download Flash Player